CVS HEALTH CORPORATION Dividends, Common Stock
CVS HEALTH CORPORATION (CVS) reported Dividends, Common Stock of $863.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity
us-gaap:DividendsCommonStock · last filed 2026-08-05
- CVS HEALTH CORPORATION dividends, common stock for the quarter ending 2026-06-30 was $863.00M, a 1.17% increase year-over-year.
- CVS HEALTH CORPORATION dividends, common stock for the quarter ending 2026-03-31 was $857.00M, a 1.06% increase year-over-year.
- CVS HEALTH CORPORATION dividends, common stock for the quarter ending 2025-09-30 was $854.00M, a 0.95% increase year-over-year.
- CVS HEALTH CORPORATION dividends, common stock for the quarter ending 2025-06-30 was $853.00M, a 0.83% increase year-over-year.
- CVS HEALTH CORPORATION dividends, common stock for fiscal 2025 was $3.41B, a 0.83% increase from fiscal 2024.
- CVS HEALTH CORPORATION dividends, common stock for fiscal 2024 was $3.38B, a 7.74% increase from fiscal 2023.
- CVS HEALTH CORPORATION dividends, common stock for fiscal 2023 was $3.14B, a 7.84% increase from fiscal 2022.
- CVS HEALTH CORPORATION dividends, common stock for fiscal 2022 was $2.91B, a 10.06% increase from fiscal 2021.
| Period end | Dividends, Common Stock 3 month | Dividends, Common Stock 6 month | Dividends, Common Stock 9 month | Dividends, Common Stock 12 month |
|---|---|---|---|---|
| 2026-06-30 | $863.00M 10-Q · filed 2026-08-05 | $1.72B derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $857.00M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $3.41B 10-K · filed 2026-02-10 | |||
| 2025-09-30 | $854.00M 10-Q · filed 2025-10-29 | $1.71B derived: sum of 2 quarters · filed 2026-08-05 | $2.56B derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $853.00M 10-Q · filed 2026-08-05 | $1.70B derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $848.00M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $3.38B 10-K · filed 2026-02-10 | |||
| 2024-09-30 | $846.00M 10-Q · filed 2025-10-29 | $1.69B derived: sum of 2 quarters · filed 2025-10-29 | $2.54B derived: sum of 3 quarters · filed 2025-10-29 | |
| 2024-06-30 | $846.00M 10-Q · filed 2025-10-29 | $1.69B derived: sum of 2 quarters · filed 2025-10-29 | ||
| 2024-03-31 | $844.00M 10-Q · filed 2025-10-29 | |||
| 2023-12-31 | $3.14B 10-K · filed 2026-02-10 | |||
| 2023-09-30 | $786.00M 10-Q · filed 2024-11-06 | $1.57B derived: sum of 2 quarters · filed 2024-11-06 | $2.35B derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $786.00M 10-Q · filed 2024-11-06 | $1.57B derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $781.00M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $2.91B 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $723.00M 10-Q · filed 2023-11-01 | $1.45B derived: sum of 2 quarters · filed 2023-11-01 | $2.18B derived: sum of 3 quarters · filed 2023-11-01 | |
| 2022-06-30 | $729.00M 10-Q · filed 2023-11-01 | $1.46B derived: sum of 2 quarters · filed 2023-11-01 | ||
| 2022-03-31 | $730.00M 10-Q · filed 2023-11-01 | |||
| 2021-12-31 | $2.64B 10-K · filed 2024-02-07 | |||
| 2021-09-30 | $665.00M 10-Q · filed 2022-11-02 | $1.32B derived: sum of 2 quarters · filed 2022-11-02 | $1.98B derived: sum of 3 quarters · filed 2022-11-02 | |
| 2021-06-30 | $655.00M 10-Q · filed 2022-11-02 | $1.31B derived: sum of 2 quarters · filed 2022-11-02 | ||
| 2021-03-31 | $660.00M 10-Q · filed 2022-11-02 | |||
| 2020-12-31 | $2.64B 8-K · filed 2023-05-25 | |||
| 2020-09-30 | $664.00M 10-Q · filed 2021-11-03 | $1.33B derived: sum of 2 quarters · filed 2021-11-03 | $1.98B derived: sum of 3 quarters · filed 2021-11-03 | |
| 2020-06-30 | $662.00M 10-Q · filed 2021-11-03 | $1.32B derived: sum of 2 quarters · filed 2021-11-03 | ||
| 2020-03-31 | $657.00M 10-Q · filed 2021-11-03 | |||
| 2019-12-31 | $2.62B 10-K · filed 2022-02-09 | |||
| 2019-09-30 | $649.00M 10-Q · filed 2020-11-06 | $1.31B derived: sum of 2 quarters · filed 2020-11-06 | $1.96B derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $659.00M 10-Q · filed 2020-11-06 | $1.31B derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | $651.00M 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $2.04B 10-K · filed 2021-02-16 | |||
| 2018-09-30 | $512.00M 10-Q · filed 2019-11-06 | $1.02B derived: sum of 2 quarters · filed 2019-11-06 | $1.53B derived: sum of 3 quarters · filed 2019-11-06 | |
| 2018-06-30 | $512.00M 10-Q · filed 2019-11-06 | $1.02B derived: sum of 2 quarters · filed 2019-11-06 | ||
| 2018-03-31 | $508.00M 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $2.05B 10-K · filed 2020-02-18 | |||
| 2016-12-31 | $1.84B 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |